INVIRAGEN, INC. — Form D/A

INVIRAGEN, INC. of FORT COLLINS, CO, a company, filed a Form D amendment with the SEC on 2010-10-08. The offering totals $15.3M, of which $9.9M was reported sold. Industry: Biotechnology.

Offering

Filed: 2010-10-08
Form: D/A
Accession: 0001461681-10-000002
Industry: Biotechnology
Exemptions: 06
Total offering: $15.3M
Amount sold: $9.9M
Remaining: $5.5M
Investors: 24
Date of first sale: 2009-09-22
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-134986

Issuer

Name: INVIRAGEN, INC.
CIK: 0001461681
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2006
Address: 1613 PROSPECT PARKWAY, FORT COLLINS, CO, 80525
Phone: 970-672-4918

Officers, directors & promoters (10)

Name	Role	Location
JERRY TONG SADOFF	Director	FORT COLLINS, CO
REX R O'NEAL	Executive Officer	BOULDER, CO
JORGE OSORIO	Executive Officer	FORT COLLINS, CO
JORGE OSORIO	Promoter	FORT COLLINS, CO
HENG TONG CHOO	Director	RAFFLES CITY TOWER, U0
DAN STINCHCOMB	Director	FORT COLLINS, CO
DAN STINCHCOMB	Executive Officer	FORT COLLINS, CO
DAN STINCHCOMB	Promoter	FORT COLLINS, CO
JOHN TONG NEIS	Director	MADISON, WI
FRED TONG SCHWARZER	Director	PALO ALTO, CA

Other filings by this issuer (3)

Filed	Form	Offering	Sold
2012-01-24	D/A	$15.3M	$15.3M
2009-10-06	D	$15.3M	$4.4M
2009-10-06	D	$2.2M	$2.2M

More